In September 2005, Michelle Vanek set out to hike Mount of the Holy Cross, a 14,005-foot peak in Colorado. As she neared the top, she became too tired to go on. Her hiking partner headed for the ...
Authorities have arrested a man acccused of sparking the Palisades Fire that devastated parts of Los Angeles at the start of the year, leaving at least a dozen people dead and thousands without homes.
Researchers at Western and the University of Calgary have discovered how HIV hides in different parts of the body by embedding itself into the DNA of cells in a tissue-specific manner, offering new ...
The S&P 500, Dow Jones Industrial Average, and Nasdaq Composite are soaring -- and so are stock valuations. Rare commentary on the state of equity valuations from the head of the Federal Reserve ...
I’m a huge fan of PlayStation’s first-party offerings. They’ve come to embody the sort of cinematic adventures I’ve always looked for when sitting down with a controller in my hand, feeling like ...
You go to the movies for all kinds of reasons. Sometimes, you might find yourself there to cry, or laugh, or contemplate some of the biggest questions we face as a species. One thing movies can do is, ...
Women's cycling Reflections from Rwanda – Eight things we learned at the World Championships Women's cycling 'It is our time to show them what we can do' - World Championships make history in Rwanda ...
“How did a fat computer hacker get abs like this?“ Dave Asprey is looking at his body. “Like, I have veins.” The tech-exec-turned-biohacker tilts his phone screen toward his six-pack. “And I’m 52,” he ...
This post is part one of a series. Speaking feels like the most natural thing in the world. You think a thought, open your mouth, and words tumble out in perfect sequence. Yet this apparent simplicity ...
Current political and economic issues succinctly explained. Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the day. Subscribe to the ...
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback